Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica.
Journal: Multiple sclerosis and related disorders
Published: July 18, 2013
Targeting gC1qR domains for therapy against infection and inflammation.
Journal: Advances in experimental medicine and biology
Published: February 14, 2013
Structure-function studies using deletion mutants identify domains of gC1qR/p33 as potential therapeutic targets for vascular permeability and inflammation.
Journal: Frontiers in immunology
Published: January 28, 2012
Showing 1-4 of 4
Last Updated: 09/26/2026